Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/27789
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Bridoux, Alexandre | - |
dc.contributor.author | Cui, Huadong | - |
dc.contributor.author | Dyskin, Evgeny | - |
dc.contributor.author | Schmitzer, Andreea Ruxandra | - |
dc.contributor.author | Mousa, Shaker A. | - |
dc.date.accessioned | 2022-07-07T10:23:21Z | - |
dc.date.available | 2022-07-07T10:23:21Z | - |
dc.date.issued | 2010-06-01 | - |
dc.identifier.citation | Bridoux, A. vd. (2010). "Semisynthesis and pharmacological activities of thyroxine analogs: Development of new angiogenesis modulators". Bioorganic and Medicinal Chemistry Letters, 20(11), 3394-3398. | en_US |
dc.identifier.issn | 0960-894X | - |
dc.identifier.issn | 1464-3405 | - |
dc.identifier.uri | https://doi.org/10.1016/j.bmcl.2010.04.011 | - |
dc.identifier.uri | https://www.sciencedirect.com/science/article/pii/S0960894X10004713 | - |
dc.identifier.uri | http://hdl.handle.net/11452/27789 | - |
dc.description.abstract | Novel thyroxine analogs with hindered phenol, amino and carboxylic acid groups have been synthesized and the effects of the synthesized compounds on angiogenesis using the chick chorioallantoic membrane and mouse matrigel models have been tested. Pharmacological profiles revealed that thyroxine tolerates numerous modifications on the amino group and remains active. These results provide the rationale for the selection of a novel thyroxine nanoparticle precursor. | en_US |
dc.description.sponsorship | Charitable Leadership Foundation | en_US |
dc.description.sponsorship | Medical Technology Acceleration Program | en_US |
dc.description.sponsorship | Pharmaceutical Research Institute | en_US |
dc.language.iso | en | en_US |
dc.publisher | Pergamon-Elsevier Science | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Thyroxine | en_US |
dc.subject | Esterification | en_US |
dc.subject | Silylation | en_US |
dc.subject | UV-vis | en_US |
dc.subject | Angiogenesis | en_US |
dc.subject | Nanopharmaceutical technology | en_US |
dc.subject | Extracelluler segment | en_US |
dc.subject | Crystal-structure | en_US |
dc.subject | Thyhroid-hormone | en_US |
dc.subject | Force-field | en_US |
dc.subject | Proteins | en_US |
dc.subject | Pharmacology & pharmacy | en_US |
dc.subject | Chemistry | en_US |
dc.subject.mesh | Angiogenesis inhibitors | en_US |
dc.subject.mesh | Animals | en_US |
dc.subject.mesh | Chick embryo | en_US |
dc.subject.mesh | Mice | en_US |
dc.subject.mesh | Models, molecular | en_US |
dc.subject.mesh | Thyroxine | en_US |
dc.title | Semisynthesis and pharmacological activities of thyroxine analogs: Development of new angiogenesis modulators | en_US |
dc.type | Article | en_US |
dc.identifier.wos | 000277788900043 | tr_TR |
dc.identifier.scopus | 2-s2.0-77953293160 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Veterinerlik Fakültesi/Temel Bilimler Bölümü. | tr_TR |
dc.contributor.orcid | 0000-0002-5600-8162 | tr_TR |
dc.identifier.startpage | 3394 | tr_TR |
dc.identifier.endpage | 3398 | tr_TR |
dc.identifier.volume | 20 | tr_TR |
dc.identifier.issue | 11 | tr_TR |
dc.relation.journal | Bioorganic and Medicinal Chemistry Letters | en_US |
dc.contributor.buuauthor | Yalçın, Murat | - |
dc.contributor.researcherid | AAG-6956-2021 | tr_TR |
dc.relation.collaboration | Yurt dışı | tr_TR |
dc.identifier.pubmed | 20434332 | tr_TR |
dc.subject.wos | Chemistry, medicinal | en_US |
dc.subject.wos | Chemistry, organic | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | Pubmed | en_US |
dc.wos.quartile | Q2 | en_US |
dc.contributor.scopusid | 57192959734 | tr_TR |
dc.subject.scopus | Tetraiodothyroacetic Acid; Thyroid Hormones; Nano-Diamino-Tetrac | en_US |
dc.subject.emtree | Amino acid | en_US |
dc.subject.emtree | Angiogenesis inhibitor | en_US |
dc.subject.emtree | Matrigel | en_US |
dc.subject.emtree | Thyroxine derivative | en_US |
dc.subject.emtree | Angiogenesis | en_US |
dc.subject.emtree | Animal experiment | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Chick | en_US |
dc.subject.emtree | Chorioallantois | en_US |
dc.subject.emtree | Controlled study | en_US |
dc.subject.emtree | Drug activity | en_US |
dc.subject.emtree | Drug effect | en_US |
dc.subject.emtree | Drug synthesis | en_US |
dc.subject.emtree | Drug tolerability | en_US |
dc.subject.emtree | Mouse | en_US |
dc.subject.emtree | Nonhuman | en_US |
Appears in Collections: | Scopus Web of Science |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.